Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Second Primary × Anthracyclines × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 16 Leukemia, Myeloid, Acute 7 Triple Negative Breast Neoplasms 4 Leukemia 3 Cardiotoxicity 2 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neoplasms, Second Primary 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid 1 HER2-negative Breast Cancer 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1 Biliary Tract Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Drug Therapy 3 Temozolomide 2 Radiotherapy 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 sacubitril and valsartan sodium hydrate drug combination 1 icotinib 1 beta Carotene 1 avelumab 1 alpha-Tocopherol 1 Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Thalidomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Semen Analysis 1 Registries 1 Radiosurgery 1 Probiotics 1 Patient Reported Outcome Measures 1 Panitumumab 1 Nicotine Chewing Gum 1 Myofascial Release Therapy 1 Megestrol Acetate 1 Lenalidomide 1 Isotretinoin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡